AI market crash: How to spot the bargains without risking your account

Investing.com — The AI reckoning has arrived. A massive tech selloff—sparked by fears of tighter regulation following this week’s U.S. election results—just erased an estimated $2.5 trillion in total market value from the Nasdaq Composite.

The carnage spread rapidly from chipmakers and data center developers to power providers, resulting in a drop not seen since the height of the pandemic in March 2020. The benchmark S&P 500 slumped 4.36%, while the Dow Jones Industrial Average plummeted 3.44%. Volatility saw its biggest daily jump in a year, and the bleeding didn’t stop at the U.S. border. Asian markets took a historic hit, with Taiwan’s key index dipping into bear market territory and South Korean semiconductor giants triggering circuit breakers.

When a sector slumps this violently, the biggest danger isn’t missing the bounce—it’s walking straight into a value trap. A stock doesn’t become a bargain simply because it lost 15% in a morning. If business fundamentals are deteriorating, cash flows are dwindling, and regulatory headwinds are mounting, what looks like a discount today can easily become a deeper loss tomorrow.

But while traders frantically unloaded overextended tech stocks yesterday, one under-the-radar healthcare name jumped 22% in a single session on breakout earnings.

Separating genuine discounts from falling knives is exactly why ProPicks AI exists. Instead of chasing hype, our quantitative engine processes over 15 years of financial metrics across 60,000 global companies to spot mispriced assets with rock-solid underlying fundamentals.

While traders frantically unloaded overextended tech stocks yesterday, one of ProPicks AI’s core selections—acute care hospital operator Ardent Health (NYSE: ARDT)—bucked the carnage entirely, jumping 22%. That single-day surge brings Ardent’s gains to +32.17% in November alone, and +80.89% since it was first picked.

The stock rallied following its November 4 financial release, where it crushed consensus estimates with an EPS of $0.31 (a 34.8% beat) on solid revenues of $1.62 billion. This upside materialized as the company executed rigorous cost-discipline measures, recently raising its IMPACT program savings targets to over $70 million for the year. Backed by robust operating cash flow and a healthy balance sheet, Ardent drew aggressive accumulation as the market repriced its profitability outlook.

Finding a stock like Ardent in the middle of a tech crash isn’t about luck. It requires evaluating fundamentals over hype.

What the data showed before the surge

Our machine learning engine selected Ardent Health back in December 2025 as a contrarian value-and-recovery setup rather than a pure momentum play. It identified a compelling risk-reward profile backed by operational leverage and underlying demand.

Here is exactly what the model flagged months before this week’s breakout:

• Deeply Discounted Valuation: On December 1, 2025, shares traded at just $8.79—representing a 7.4x P/E, 6.9x EV/EBITDA, and a market cap of just $1.26 billion. Backed by a supportive 5.7% free cash flow yield, this steep valuation discount created substantial upside optionality if earnings stabilized.
• Strong Top-Line Demand: In Q3 2025, revenue reached $1.58 billion, up 8.8% year-over-year. Admissions climbed 5.8% while adjusted admissions rose 2.9%, underpinned by hospital facilities operating in geographic markets growing two to three times faster than the national average.
• Visible Operating Leverage: Adjusted EBITDA surged 46% year-over-year to $143 million in Q3 2025, driving an EBITDA margin expansion of 240 basis points. The model flagged this acceleration as clear evidence that top-line gains were beginning to convert directly into bottom-line profitability.
• Guidance Reset & Operational Optionality: A previous guidance reduction in 2025 adjusted EBITDA dampened broader market sentiment, but it lowered the forward earnings hurdle. In response, Ardent launched targeted efficiency programs across labor, supply chain, and contracting, initially targeting more than $40 million in annual run-rate benefits—a target they are now vastly exceeding.

A long list of winners each month

Ardent Health is far from the only big win. Here are just a few of November’s standout performers less than a week into the month:

• Ardent Health (NYSE:ARDT): +32.17% in Nov alone (+80.89% since picked)
• CONMED (NYSE:CNMD): +19.28% in Nov alone
• Bobs Discount Furniture (NYSE:BOBS): +17.5% in Nov alone
• Kyndryl Holdings (NYSE:KD): +16.99% in Nov alone (+31.22% since picked)
• LivaNova PLC (NASDAQGS:LIVN): +15.41% in Nov alone

Among many more!

And the gains don’t stop with November. Our longer-term winners continue to compound gains for members who were positioned early:

• Everforth (NYSE:EFOR): +102.39% since picked
• Ardent Health (NYSE:ARDT): +80.89% since picked
• Consensus Cloud Solutions (NASDAQGS:CCSI): +70.74% since picked
• Delek US Holdings (NYSE:DK): +66.61% since picked
• Nucor (NYSE:NUE): +54.67% since picked

Among dozens more!

Backed by professional-grade financial intelligence, our monthly-updated list of tech picks has absolutely crushed the broader market despite the latest rout, posting a +147.69% return since launching in November 2023. That is an incredible +74.08% outperformance over the benchmark S&P 500.

*These are real-world numbers, recorded since the official launch of our AI models in November 2023.

That is the power of moving out of overextended names and finding fresh value before the crowd does. With ProPicks, subscribers don’t just receive a list of tickers. They gain access to the precise rationale behind every single addition and removal across our strategies, helping investors make informed, data-backed decisions before the broader market reacts.

Do not miss the opportunity to review the full list of November picks and see exactly where the smart money is moving next.

As part of our Early Bird Sale, you can secure an InvestingPro subscription for up to 55% off!

• Already a member? Jump straight to the FULL list of November picks HERE.
• Not yet a member? Here’s your opportunity to access the full list now
  • App users can subscribe here
  • Web users can subscribe here

How the AI Stock Picker Works

At the beginning of each month, our proprietary AI system evaluates thousands of global equities using a complex blend of historical data, valuation signals, and forward-looking growth metrics.

By processing more than 15 years of financial data across more than 150 quantitative models, the engine identifies up to 20 high-conviction stocks per strategy based on their projected medium-term upside potential.

Every month, these strategies undergo a strict rebalancing process. New opportunities are added, strong performers are retained, and stocks that no longer meet the criteria are removed.

To consistently track performance, each strategy utilizes equal weighting across all selected stocks. While investors are free to adjust their own allocations, this structure provides a transparent benchmark for evaluating overall model performance.

The objective is to systematically reposition capital toward the strongest opportunities as market conditions evolve.

Disclaimer: Subscription prices mentioned in articles are accurate at the time of publication. We regularly test different offers for our members, which may vary by region.